These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 27445264)

  • 21. CTLA-4Ig immunotherapy of obesity-induced insulin resistance by manipulation of macrophage polarization in adipose tissues.
    Fujii M; Inoguchi T; Batchuluun B; Sugiyama N; Kobayashi K; Sonoda N; Takayanagi R
    Biochem Biophys Res Commun; 2013 Aug; 438(1):103-9. PubMed ID: 23872146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peroxisome proliferator-activated receptor-alpha activation and dipeptidyl peptidase-4 inhibition target dysbiosis to treat fatty liver in obese mice.
    Silva-Veiga FM; Miranda CS; Vasques-Monteiro IML; Souza-Tavares H; Martins FF; Daleprane JB; Souza-Mello V
    World J Gastroenterol; 2022 May; 28(17):1814-1829. PubMed ID: 35633911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, attenuates cardiac dysfunction after myocardial infarction independently of DPP-4.
    Yamaguchi T; Watanabe A; Tanaka M; Shiota M; Osada-Oka M; Sano S; Yoshiyama M; Miura K; Kitajima S; Matsunaga S; Tomita S; Iwao H; Izumi Y
    J Pharmacol Sci; 2019 Feb; 139(2):112-119. PubMed ID: 30638989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emodin inhibits lipid accumulation and inflammation in adipose tissue of high-fat diet-fed mice by inducing M2 polarization of adipose tissue macrophages.
    Yu F; Yu N; Peng J; Zhao Y; Zhang L; Wang X; Xu X; Zhou J; Wang F
    FASEB J; 2021 Jul; 35(7):e21730. PubMed ID: 34110631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice.
    Prieur X; Mok CY; Velagapudi VR; Núñez V; Fuentes L; Montaner D; Ishikawa K; Camacho A; Barbarroja N; O'Rahilly S; Sethi JK; Dopazo J; Orešič M; Ricote M; Vidal-Puig A
    Diabetes; 2011 Mar; 60(3):797-809. PubMed ID: 21266330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exercise training inhibits inflammation in adipose tissue via both suppression of macrophage infiltration and acceleration of phenotypic switching from M1 to M2 macrophages in high-fat-diet-induced obese mice.
    Kawanishi N; Yano H; Yokogawa Y; Suzuki K
    Exerc Immunol Rev; 2010; 16():105-18. PubMed ID: 20839495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation.
    Zhuang G; Meng C; Guo X; Cheruku PS; Shi L; Xu H; Li H; Wang G; Evans AR; Safe S; Wu C; Zhou B
    Circulation; 2012 Jun; 125(23):2892-903. PubMed ID: 22580331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-130b promotes obesity associated adipose tissue inflammation and insulin resistance in diabetes mice through alleviating M2 macrophage polarization via repression of PPAR-γ.
    Zhang M; Zhou Z; Wang J; Li S
    Immunol Lett; 2016 Dec; 180():1-8. PubMed ID: 27746169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibiting Glycogen Synthase Kinase 3 Reverses Obesity-Induced White Adipose Tissue Inflammation by Regulating Apoptosis Inhibitor of Macrophage/CD5L-Mediated Macrophage Migration.
    Wang L; Wang Y; Zhang C; Li J; Meng Y; Dou M; Noguchi CT; Di L
    Arterioscler Thromb Vasc Biol; 2018 Sep; 38(9):2103-2116. PubMed ID: 30026270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diet-induced adipose tissue inflammation and liver steatosis are prevented by DPP-4 inhibition in diabetic mice.
    Shirakawa J; Fujii H; Ohnuma K; Sato K; Ito Y; Kaji M; Sakamoto E; Koganei M; Sasaki H; Nagashima Y; Amo K; Aoki K; Morimoto C; Takeda E; Terauchi Y
    Diabetes; 2011 Apr; 60(4):1246-57. PubMed ID: 21330637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-30 modulates metabolic inflammation by regulating Notch signaling in adipose tissue macrophages.
    Miranda K; Yang X; Bam M; Murphy EA; Nagarkatti PS; Nagarkatti M
    Int J Obes (Lond); 2018 Jun; 42(6):1140-1150. PubMed ID: 29899524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High dose of linagliptin induces thermogenic beige adipocytes in the subcutaneous white adipose tissue in diet-induced obese C57BL/6 mice.
    de Oliveira Correia BR; Rachid TL; de Oliveira Glauser JS; Martins FF; Mandarim-de-Lacerda CA; Souza-Mello V
    Endocrine; 2019 Aug; 65(2):252-262. PubMed ID: 31161561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in kidney-specific DPP-4 inhibition by linagliptin and sitagliptin.
    Luippold G; Mark M; Klein T; Amann K; Daniel C
    Diabetes Res Clin Pract; 2018 Sep; 143():199-203. PubMed ID: 30031047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amelioration of obesity-associated inflammation and insulin resistance in c57bl/6 mice via macrophage polarization by fish oil supplementation.
    Bashir S; Sharma Y; Elahi A; Khan F
    J Nutr Biochem; 2016 Jul; 33():82-90. PubMed ID: 27260471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Telmisartan improves insulin resistance and modulates adipose tissue macrophage polarization in high-fat-fed mice.
    Fujisaka S; Usui I; Kanatani Y; Ikutani M; Takasaki I; Tsuneyama K; Tabuchi Y; Bukhari A; Yamazaki Y; Suzuki H; Senda S; Aminuddin A; Nagai Y; Takatsu K; Kobayashi M; Tobe K
    Endocrinology; 2011 May; 152(5):1789-99. PubMed ID: 21427223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macrophage VLDLR mediates obesity-induced insulin resistance with adipose tissue inflammation.
    Shin KC; Hwang I; Choe SS; Park J; Ji Y; Kim JI; Lee GY; Choi SH; Ching J; Kovalik JP; Kim JB
    Nat Commun; 2017 Oct; 8(1):1087. PubMed ID: 29057873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of dipeptidyl peptidase 4 inhibition on inflammation in atherosclerosis: A
    Virta J; Hellberg S; Liljenbäck H; Ståhle M; Silvola JMU; Huusko J; Söderström M; Knuuti J; Nuutila P; Ylä-Herttuala S; Gomez MF; Roivainen A; Saraste A
    Atherosclerosis; 2020 Jul; 305():64-72. PubMed ID: 32386751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Linagliptin but not Sitagliptin inhibited transforming growth factor-β2-induced endothelial DPP-4 activity and the endothelial-mesenchymal transition.
    Shi S; Kanasaki K; Koya D
    Biochem Biophys Res Commun; 2016 Feb; 471(1):184-90. PubMed ID: 26826382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DPP-4 Inhibitor Linagliptin Ameliorates Oxidized LDL-Induced THP-1 Macrophage Foam Cell Formation and Inflammation.
    Wang H; Li Y; Zhang X; Xu Z; Zhou J; Shang W
    Drug Des Devel Ther; 2020; 14():3929-3940. PubMed ID: 33061298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dipeptidyl peptidase IV inhibitor sitagliptin reduces local inflammation in adipose tissue and in pancreatic islets of obese mice.
    Dobrian AD; Ma Q; Lindsay JW; Leone KA; Ma K; Coben J; Galkina EV; Nadler JL
    Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E410-21. PubMed ID: 21081706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.